A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

S. 5059119th Congress

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Introduced in the SenateSen. Ashley Moody (R-FL)3 sections · 1 min read

Version: Introduced in Senate · Jul 21, 2026

Section 1. Streamlining biosimilar reviews

Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 262(k)(5)) is amended—

(1) by striking subparagraph (B); and

(2) by redesignating subparagraph (C) as subparagraph (B).

to ask questions about this bill.